
Revolutionary Gene Editing Trial Shows Promise for Sickle Cell Cure in First Patients
Naomi Feldman
On May 22, 2024, a pioneering clinical trial utilizing advanced CRISPR gene-editing technology announced promising early results in curing sickle cell disease, a debilitating genetic blood disorder affecting millions worldwide.…
Continue Reading













